What does the future health outlook for Asia look like? What are the key drivers for lifestyle driven diseases? Check out this presentation by futurist Anders Sorman-Nilsson

1. The Asian Future Lab

2. Digital Disruption
Anders Sorman-Nilsson (LLB MBA) is
the founder of Thinque - a strategy
think tank that helps executives and
leaders convert disruptive questions
into proactive, future strategies.
As an Australian-Swedish futurist
and innovation strategist he has
helped executives and leaders on 4
continents map, prepare for, and
strategise for foreseeable and
unpredictable futures.
www.thinquetank.com

3. Demographic Dividend
Life Expectancy
Income Per Person

4. Demographic Dividend
Life Expectancy
Income Per Person

5. Affluence Continues to Increase in APAC
China India Indonesia Malaysia Philippines Signapore Taiwan Thailand Vietnam
* World Income Distribution Report (Euromonitor)

6. Affluence Continues to Increase in APAC
3
2.25
1.5
0.75
0
1990 2000 2007
China India Indonesia Malaysia Philippines Signapore Taiwan Thailand Vietnam
* World Income Distribution Report (Euromonitor)

7. Affluence Continues to Increase in APAC
3
0.32 0.32
0.26
2.25 0.34 0.34 0.34
0.23 0.23 0.23
0.31 0.3 0.3
1.5
0.38 0.39 0.39
0.33 0.33 0.33
0.75 0.28 0.21 0.21
0.27 0.27
0.24
0.27 0.31 0.31
0
1990 2000 2007
China India Indonesia Malaysia Philippines Signapore Taiwan Thailand Vietnam
* World Income Distribution Report (Euromonitor)

8. Future Urbanization Trends in Asian Countries
2000 Trend 1 2010 Trend 2 2020 Trend 3 2030 Trend 4
* Population Division of DESA of UN

9. Future Urbanization Trends in Asian Countries
0.9
0.675
0.45
0.225
0
India Indonesia Pakistan Bangladesh Korea
2000 Trend 1 2010 Trend 2 2020 Trend 3 2030 Trend 4
* Population Division of DESA of UN

10. Future Urbanization Trends in Asian Countries
0.9
0.675
0.45 86.3%
79.6%
68.9%
49.8%
0.225 40.6% 42% 41%
33.2%
27.7%
23.6%
0
India Indonesia Pakistan Bangladesh Korea
2000 Trend 1 2010 Trend 2 2020 Trend 3 2030 Trend 4
* Population Division of DESA of UN

11. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic Disease Other Diseases Injury * WHO, 2012

12. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic Disease Other Diseases Injury * WHO, 2012

13. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic
Disease
Chronic Disease Other Diseases Injury * WHO, 2012

14. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic
Disease
Chronic Disease Other Diseases Injury * WHO, 2012

15. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic
Disease
Chronic Disease Other Diseases Injury * WHO, 2012

16. Urbanization Goes Hand in Hand with Increasing Chronic Diseases
1990 2020
Chronic Chronic
Disease Disease
Chronic Disease Other Diseases Injury * WHO, 2012

17. APAC HC Expenditure to Increase 151% by 2020

18. Global v APAC: The New Healthcare Frontier
APAC Rest of World
* Frost & Sullivan, APAC Healthcare Outlook, 2011 - 2015

19. Global v APAC: The New Healthcare Frontier
2000
1500
1000
500
0
2011 2012 2013 2014 2015
APAC Rest of World
* Frost & Sullivan, APAC Healthcare Outlook, 2011 - 2015

20. Global v APAC: The New Healthcare Frontier
2000
1500
1000
CAGR: 4.3%
500
0
2011 2012 2013 2014 2015
APAC Rest of World
* Frost & Sullivan, APAC Healthcare Outlook, 2011 - 2015

21. Global v APAC: The New Healthcare Frontier
2000
1500
1000
CAGR: 4.3%
500
CAGR: 12.1%
0
2011 2012 2013 2014 2015
APAC Rest of World
* Frost & Sullivan, APAC Healthcare Outlook, 2011 - 2015

22. Global v APAC: The New Healthcare Frontier
2000
1500
1000
CAGR: 4.3%
500
CAGR: 12.1%
0
2011 2012 2013 2014 2015
APAC Rest of World
* Frost & Sullivan, APAC Healthcare Outlook, 2011 - 2015

23. Soft Drink
Sales in 2011

24. Soft Drink
Sales in 2011

25. Soft Drink
Sales in 2011

26. Soft Drink
Sales in 2011

27. Soft Drink
Sales in 2011
Sugar is
on the Rise!

28. Packaged Food Sales on the Increase in Asia

29. Comparing Diabetes Prevalence 2010 - 2030
China
USA
India
Japan
*International Diabetes Federation

30. Comparing Diabetes Prevalence 2010 - 2030
China
USA
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

31. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China
USA
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

32. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
USA
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

33. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

34. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA 12%
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

35. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA 12%
7%
India
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

36. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA 12%
7%
India 9.5%
Japan
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

37. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA 12%
7%
India 9.5%
Japan 5%
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

38. Comparing Diabetes Prevalence 2010 - 2030
4.2%
China 5%
10.2%
USA 12%
7%
India 9.5%
Japan 5%
5.9%
0 0.03 0.06 0.09 0.12
*International Diabetes Federation

39. Pharma Market Forecast @ $ 310.2bn by 2016
Asia-Pacific Pharma Market Value Forecast * Marketline

40. Pharma Market Forecast @ $ 310.2bn by 2016
320
240
160
80
0
2011 2012 2013 2014 2015 2016
Asia-Pacific Pharma Market Value Forecast * Marketline

41. Pharma Market Forecast @ $ 310.2bn by 2016
320
240
160
80
0
2011 2012 2013 2014 2015 2016
Asia-Pacific Pharma Market Value Forecast * Marketline

42. Pharma Market Forecast @ $ 310.2bn by 2016
42.9% growth from 2011
320
240
160
80
0
2011 2012 2013 2014 2015 2016
Asia-Pacific Pharma Market Value Forecast * Marketline

43. Pharma Market Forecast @ $ 310.2bn by 2016
42.9% growth from 2011
320
240
160
80
0
2011 2012 2013 2014 2015 2016
Asia-Pacific Pharma Market Value Forecast * Marketline

45. Who is Anders?
Anders Sorman-Nilsson (LLB MBA) is the founder of Thinque - a strategy think tank that helps
executives and leaders convert disruptive questions into proactive, future strategies.
As an Australian-Swedish futurist and innovation strategist he has helped executives and
leaders on 4 continents map, prepare for, and strategise for both foreseeable and unpredictable
futures. Since founding Thinque in 2005, he has worked with and spoken to clients like Xerox,
Apple, Johnson & Johnson, Cisco, Eli Lilly, SAP, IBM, ABN Amro Bank, Commonwealth Bank,
McCann Erickson and BAE Systems, across diverse cultural and geographic contexts.
Anders is an active member of TEDGlobal (Oxford 2009 / Edinburgh 2011), has keynoted at
TEDx, guest lectured at University of Technology Sydney Business School, and Anders is on the
prestigious 2013 Million Dollar Roundtable roster. He is a member of the University of Sydney
Global Executive MBA cohort, and has completed executive education at Stanford University and
the Indian Institute of Management, Bangalore.

46. Enquire now www.anderssorman-nilsson.com

47. Testimonials
“There are those special moments when the right ideas and the right people collide to make magic. This is
one of those times. I want to say a HUGE THANK YOU for all your work to make the Senior Director
Conference both an engaging experience, and a catalyst for change.”
CMO Asia, Fortune 500, Pharmaceutical Industry
“Anders provided an engaging and energetic presentation of real and relevant information to the business
that could be used in all areas across the business both now and moving into the future.“
Head of Regional Portfolio Management Asia, Fortune 500, FMCG
“Anders' presentation style and fresh content were an excellent and inspirational start to our Summit. It
resulted in only positive feedback from the audience. Anders is very professional and a brilliant thinker and
communicator!”
Management Consultant, Fortune 1000, Banking Industry

48. The Asian Future Lab